XBP1 and colitis: This present study was undertaken to investigate the mechanism of action of (±)-8-ADC prevention of the development of colonic inflammation, and it was found to act via the XBP1-NF-κB pathway in a DSS-induced colitis mouse model and the IEC6 cell line.